Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Safety of Chemotherapy for Patients With Gynecological Malignancy in High-risk Region of COVID-19, a Prospective Cohort Study

NCT04341480 is registered in ClinicalTrials.gov with Tongji Hospital as lead sponsor.

NCT NCT04341480
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04341480 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Safety of Chemotherapy for Patients With Gynecological Malignancy in High-risk Region of COVID-19, a Prospective Cohort Study
Lead sponsor
Tongji Hospital
Phase
Observational
Overall status
Unknown status
Start date
July 1, 2020
Completion date
January 10, 2023
Enrollment
305 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

gynecological cancer